文献速递脑血管病

基于新分型的非急性颅内椎动脉闭塞血管内再通研究

Endovascular Recanalization for Nonacute Intracranial Vertebral Artery Occlusion According to a New Classification.
PubMed 文献 · Stroke · 2020-08-25

该回顾性研究分析50例症状性动脉粥样硬化性非急性颅内椎动脉闭塞患者,评估血管内再通可行性与安全性并提出造影分型。38例(76%)再通成功,30天内卒中或死亡4%(2/50)。I至IV型再通率递减(94.1%、76.9%、70%、50%,P=0.012),围术期并发症递增(0.0%、7.7%、20%、50%,P=0.001)。

要点

  • 非急性颅内椎动脉闭塞血管内再通总体再通率76%,30天卒中或死亡4%。
  • 新造影分型I至IV型再通率递减、围术期并发症递增。
  • I型和II型患者可能更适合血管内再通治疗。

核心结论

  • 对经选择的症状性动脉粥样硬化性非急性颅内椎动脉闭塞患者,血管内再通可能可行且安全,可作为替代治疗,尤其适用于I型和II型患者。

研究设计与样本

  • 回顾性分析2015年1月至2019年12月共50例症状性动脉粥样硬化性非急性颅内椎动脉闭塞患者,评估再通率、围术期并发症及随访结果。
  • 全部患者按造影分型分为4组。

主要发现

  • 50例中38例(76%)实现成功再通。
  • 30天内任何卒中或死亡为4%(2/50)。
  • I至IV型再通率分别为94.1%、76.9%、70%、50%(P=0.012)。
  • I至IV型围术期并发症率分别为0.0%、7.7%、20%、50%(P=0.001)。

关键数值与推荐

  • 造影分型I至IV型再通率逐渐下降(94.1%、76.9%、70%、50%,P=0.012)。
  • 造影分型I至IV型围术期并发症率逐渐升高(0.0%、7.7%、20%、50%,P=0.001)。

临床怎么用

  • 对症状性动脉粥样硬化性非急性颅内椎动脉闭塞患者,可依据造影分型评估血管内再通的风险与获益。
  • I型和II型患者再通成功率较高、围术期并发症较低,可能更适合血管内再通。

局限性

  • 本研究为回顾性分析,样本量50例,结果需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Endovascular recanalization for patients with nonacute intracranial vertebral artery occlusion remains clinically challenging. We aim to evaluate the feasibility and safety of endovascular recanalization for nonacute intracranial vertebral artery occlusion and propose a new angiographic classification. METHODS: Fifty patients with symptomatic atherosclerotic nonacute intracranial vertebral artery occlusion from January 2015 to December 2019 were analyzed, retrospectively. The rate of recanalization, peri-procedural complications, and follow-up results were evaluated. All patients were divided into 4 groups according to an angiographic classification. RESULTS: Among the 50 patients, 38 (76%) achieved successful recanalization. Any stroke or death within 30 days was 4% (2/50). From type I to type IV, the recanalization rate gradually decreased (94.1%, 76.9%, 70%, and 50%, respectively, P=0.012), while the perioperative complication rate gradually increased (0.0%, 7.7%, 20%, and 50%, respectively, P=0.001). CONCLUSIONS: Endovascular recanalization may be feasible and safe for carefully selected patients with symptomatic atherosclerotic nonacute intracranial vertebral artery occlusion and, therefore, represents an alternative treatment, especially for type I and type II patients.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Gao F, Sun X, Zhang H, et al. Endovascular Recanalization for Nonacute Intracranial Vertebral Artery Occlusion According to a New Classification. Stroke. 2020. PMID: 32838672. doi:10.1161/STROKEAHA.120.030440

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。